Reference product in bioequivalence [Regulatives / Guidelines]
Dear Helmut,
first of all, i hope that you are doing well in these trouble period!
we would like to perform a bioequivalence (in Europe) study with our test versus a European marketed reference.
As stated in the guideline:
"For Article 10(1) and 10(3) marketing authorisation applications reference must be made to the dossier of a reference medicinal product for which a marketing authorisation is or has been granted in the Union on the basis of a complete dossier in accordance with Articles 8(3), 10a, 10b or 10c of Directive 2001/83/EC, as amended."
The problem is that the " original" reference was withdrawn from the market ( the reason is not known but the generics are yet on the market so we suppose that was not a safety reason).
What is the solution?
a generics? But which one ( there are a plenty of them)?
a out of European marketed reference? but it's not authorised..
If you have a idea... we will take it!
Many thanks for your time!
Have a nice day
Sonia
first of all, i hope that you are doing well in these trouble period!
we would like to perform a bioequivalence (in Europe) study with our test versus a European marketed reference.
As stated in the guideline:
"For Article 10(1) and 10(3) marketing authorisation applications reference must be made to the dossier of a reference medicinal product for which a marketing authorisation is or has been granted in the Union on the basis of a complete dossier in accordance with Articles 8(3), 10a, 10b or 10c of Directive 2001/83/EC, as amended."
The problem is that the " original" reference was withdrawn from the market ( the reason is not known but the generics are yet on the market so we suppose that was not a safety reason).
What is the solution?
a generics? But which one ( there are a plenty of them)?
a out of European marketed reference? but it's not authorised..
If you have a idea... we will take it!
Many thanks for your time!
Have a nice day
Sonia
Complete thread:
- Reference product in bioequivalenceslebr 2020-11-04 10:02 [Regulatives / Guidelines]